Flecainide causes a wider QRS and longer PR.
Indications for flecainide are:
- SVT with accessory pathway
Its half life is 16 hrs.
Flecainide is contraindicated post MI.
It should be used with caution in those with pacemakers as it can raise the potential needed for stimulation.
Adverse effects of flecainide include:
- negatively inotropic
- oral parasthesia
- visual disturbances
- rarely: pneumonitis
Next - Arrhythmogenic right ventricular cardiomyopathy